ijms-logo

Journal Browser

Journal Browser

Molecular and Cellar Research of Spine and Spinal Cord Injury

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 7818

Special Issue Editors


E-Mail Website
Guest Editor
School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia
Interests: intervertebral disc structure–function relationship; intervertebral disc tissue engineering; organ-on-a-chip; biomechanics and mechanobiology of the intervertebral disc; hydrogels
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Biomedical Engineering, University of Technology Sydney, Sydney, NSW 2007, Australia
Interests: isolation, characterization, and determination of the cellular responses to wear particles; spinal cord cellular responses to wear products from spinal implants, intervertebral disc and spinal cord tissue engineering, central nervous system repair, and neural stem cell and primary neural cell responses to tissue-engineered scaffolds
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Low back pain (LBP), a prevalent and debilitating condition with extensive socioeconomic impacts, is today’s major public health concern that affects the quality of life of billions of people around the world annually. Since pain can induce mental health issues and create a major annual economic burden worldwide, a call for global action was announced in the Lancet to meet the associated challenges for LBP in 2018.

Degenerative changes in spinal intervertebral discs (IVDs) are frequently detected in patients suffering LBP. Current treatments for degeneration-induced LBP include conservative methods (i.e., rehabilitation) and surgical interventions, depending on the severity of IVD degeneration. To reduce LBP in highly degenerative IVDs, biomaterial (metal, ceramic, polymers, or composites) fusion instrumentation and motion preservation devices are frequently used. However, they may limit the spine’s mobility, accelerate the degeneration of adjacent IVDs, and lead to long recovery times with notable post-surgery complications. Moreover, the generation of volumetric wear and particulate debris, which is likely to occur after total IVD replacement, is a concern which compromises the longevity of spinal implants. There are growing concerns within the neurosurgical community regarding the exposure of periprosthetic tissue—in particular, the spinal cord—to metal wear particles and ions from spinal implants. It is believed that wear particles and metallic ions affect the biological function of the spinal cord and IVD, and trigger hypersensitivity, cytotoxicity, genotoxicity, and inflammation as well as the formation of pseudotumors.

Due to the inherent restrictions associated with the use of spinal implants and to minimize their side effects on the spine and spinal cord biology, structure, and function, there is a significant unmet need for new treatment options. Tissue engineering approaches, including gene, molecular, and cell therapies to regenerate IVD, represent better options compared to the current conventional treatment and can eliminate concerns about the side effects of wear particles on the spine and spinal cord biology, structure, and function. However, despite intense research interest, attempts to regenerate IVD have failed so far, and no effective strategy has translated into a successful clinical outcome. Therefore, the focus of the proposed Special Issue is IVD and spinal cord regeneration using cell and molecular therapies to address the abovementioned challenges. The guest editors welcome bioengineers, biologists, surgeons, biomedical and mechanical engineers, health scientists, and all researchers in the field to submit their high-quality research work (Reviews, Research, Communications) falling within the scope of the Special Issue and share their state-of-the-art knowledge.

Potential topic areas include, but are not limited to:

  • Cell and molecular therapies for IVD and spinal cord regeneration, including new tissue engineering models (3D tissue-engineered scaffolds and organ-on-a-chip and microfluidic systems).
  • Current commercial approaches for molecular- and cell-based IVD and spinal cord regeneration.
  • IVD and spinal cord injury models for cell and molecular research.
  • Isolation and characterization of spinal implant wear particles, and determination of the neural and IVD cellular responses to wear particles and ions.
  • Safety and efficacy of current cell and molecular therapies for IVD and spinal cord regeneration.
  • Effective cell and molecular delivery techniques for IVD and spinal cord regeneration.
  • Physiologically relevant efficiency metrics for IVD and spinal cord regeneration.
  • Biomechanics and mechanobiology (including computational approaches) of IVD and spinal cord.
  • Biology and structure–function relationship of IVD and spinal cord and their impact on cell therapy approaches.
  • Neural and IVD stem and primary cell interactions with tissue-engineered scaffolds and hydrogel systems.

Dr. Javad Tavakoli
Prof. Dr. Joanne Tipper
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pine
  • spinal cord
  • intervertebral disc
  • tissue engineering
  • regenerative medicine
  • cell therapy
  • molecular therapy
  • injury models
  • organ-on-a-chip and microfluidic systems for cell therapy
  • mechanobiology
  • spinal implants wear particle
  • safety and efficacy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

16 pages, 1972 KiB  
Article
The Impact of Treadmill Training on Tissue Integrity, Axon Growth, and Astrocyte Modulation
by Tatyana Ageeva, Davran Sabirov, Albert Sufianov, Eldar Davletshin, Elizaveta Plotnikova, Rezeda Shigapova, Galina Sufianova, Anna Timofeeva, Yuri Chelyshev, Albert Rizvanov and Yana Mukhamedshina
Int. J. Mol. Sci. 2024, 25(7), 3772; https://doi.org/10.3390/ijms25073772 - 28 Mar 2024
Viewed by 2860
Abstract
Spinal cord injury (SCI) presents a complex challenge in neurorehabilitation, demanding innovative therapeutic strategies to facilitate functional recovery. This study investigates the effects of treadmill training on SCI recovery, emphasizing motor function enhancement, neural tissue preservation, and axonal growth. Our research, conducted on [...] Read more.
Spinal cord injury (SCI) presents a complex challenge in neurorehabilitation, demanding innovative therapeutic strategies to facilitate functional recovery. This study investigates the effects of treadmill training on SCI recovery, emphasizing motor function enhancement, neural tissue preservation, and axonal growth. Our research, conducted on a rat model, demonstrates that controlled treadmill exercises significantly improve motor functions post-SCI, as evidenced by improved scores on the Basso, Beattie, and Bresnahan (BBB) locomotor rating scale and enhanced electromyography readings. Notably, the training facilitates the preservation of spinal cord tissue, effectively reducing secondary damage and promoting the maintenance of neural fibers in the injured area. A key finding is the significant stimulation of axonal growth around the injury epicenter in trained rats, marked by increased growth-associated protein 43 (GAP43) expression. Despite these advancements, the study notes a limited impact of treadmill training on motoneuron adaptation and highlights minimal changes in the astrocyte and neuron–glial antigen 2 (NG2) response. This suggests that, while treadmill training is instrumental in functional improvements post-SCI, its influence on certain neural cell types and glial populations is constrained. Full article
(This article belongs to the Special Issue Molecular and Cellar Research of Spine and Spinal Cord Injury)
Show Figures

Figure 1

Review

Jump to: Research

16 pages, 1323 KiB  
Review
Disruption of Neuromuscular Junction Following Spinal Cord Injury and Motor Neuron Diseases
by Colin Nemeth, Naren L. Banik and Azizul Haque
Int. J. Mol. Sci. 2024, 25(6), 3520; https://doi.org/10.3390/ijms25063520 - 20 Mar 2024
Cited by 1 | Viewed by 2469
Abstract
The neuromuscular junction (NMJ) is a crucial structure that connects the cholinergic motor neurons to the muscle fibers and allows for muscle contraction and movement. Despite the interruption of the supraspinal pathways that occurs in spinal cord injury (SCI), the NMJ, innervated by [...] Read more.
The neuromuscular junction (NMJ) is a crucial structure that connects the cholinergic motor neurons to the muscle fibers and allows for muscle contraction and movement. Despite the interruption of the supraspinal pathways that occurs in spinal cord injury (SCI), the NMJ, innervated by motor neurons below the injury site, has been found to remain intact. This highlights the importance of studying the NMJ in rodent models of various nervous system disorders, such as amyotrophic lateral sclerosis (ALS), Charcot–Marie–Tooth disease (CMT), spinal muscular atrophy (SMA), and spinal and bulbar muscular atrophy (SBMA). The NMJ is also involved in myasthenic disorders, such as myasthenia gravis (MG), and is vulnerable to neurotoxin damage. Thus, it is important to analyze the integrity of the NMJ in rodent models during the early stages of the disease, as this may allow for a better understanding of the condition and potential treatment options. The spinal cord also plays a crucial role in the functioning of the NMJ, as the junction relays information from the spinal cord to the muscle fibers, and the integrity of the NMJ could be disrupted by SCI. Therefore, it is vital to study SCI and muscle function when studying NMJ disorders. This review discusses the formation and function of the NMJ after SCI and potential interventions that may reverse or improve NMJ dysfunction, such as exercise, nutrition, and trophic factors. Full article
(This article belongs to the Special Issue Molecular and Cellar Research of Spine and Spinal Cord Injury)
Show Figures

Figure 1

20 pages, 1375 KiB  
Review
Schwann Cell-Derived Exosomal Vesicles: A Promising Therapy for the Injured Spinal Cord
by Mousumi Ghosh and Damien D. Pearse
Int. J. Mol. Sci. 2023, 24(24), 17317; https://doi.org/10.3390/ijms242417317 - 10 Dec 2023
Cited by 8 | Viewed by 2059
Abstract
Exosomes are nanoscale-sized membrane vesicles released by cells into their extracellular milieu. Within these nanovesicles reside a multitude of bioactive molecules, which orchestrate essential biological processes, including cell differentiation, proliferation, and survival, in the recipient cells. These bioactive properties of exosomes render them [...] Read more.
Exosomes are nanoscale-sized membrane vesicles released by cells into their extracellular milieu. Within these nanovesicles reside a multitude of bioactive molecules, which orchestrate essential biological processes, including cell differentiation, proliferation, and survival, in the recipient cells. These bioactive properties of exosomes render them a promising choice for therapeutic use in the realm of tissue regeneration and repair. Exosomes possess notable positive attributes, including a high bioavailability, inherent safety, and stability, as well as the capacity to be functionalized so that drugs or biological agents can be encapsulated within them or to have their surface modified with ligands and receptors to imbue them with selective cell or tissue targeting. Remarkably, their small size and capacity for receptor-mediated transcytosis enable exosomes to cross the blood–brain barrier (BBB) and access the central nervous system (CNS). Unlike cell-based therapies, exosomes present fewer ethical constraints in their collection and direct use as a therapeutic approach in the human body. These advantageous qualities underscore the vast potential of exosomes as a treatment option for neurological injuries and diseases, setting them apart from other cell-based biological agents. Considering the therapeutic potential of exosomes, the current review seeks to specifically examine an area of investigation that encompasses the development of Schwann cell (SC)-derived exosomal vesicles (SCEVs) as an approach to spinal cord injury (SCI) protection and repair. SCs, the myelinating glia of the peripheral nervous system, have a long history of demonstrated benefit in repair of the injured spinal cord and peripheral nerves when transplanted, including their recent advancement to clinical investigations for feasibility and safety in humans. This review delves into the potential of utilizing SCEVs as a therapy for SCI, explores promising engineering strategies to customize SCEVs for specific actions, and examines how SCEVs may offer unique clinical advantages over SC transplantation for repair of the injured spinal cord. Full article
(This article belongs to the Special Issue Molecular and Cellar Research of Spine and Spinal Cord Injury)
Show Figures

Graphical abstract

Back to TopTop